Department of Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Brazil.
Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Brazil.
Horm Metab Res. 2020 Mar;52(3):186-193. doi: 10.1055/a-1100-7066. Epub 2020 Mar 25.
17-Hydroxylase-deficiency (17OHD) is a rare form of congenital adrenal hyperplasia. The aim of the work was to study clinical, biochemical, and the follow up of 17OHD patients and evaluate the function and structure of mutations. Brazilian patients (three 46, XX and four 46, XY; 17±1.9 years) with combined 17-hydroxylase/17,20-lyase deficiency were evaluated. gene was sequenced. Functional analysis was performed transfecting COS7 cells, which were exposed to progesterone or 17α-hydroxypregnolone substrates. Hormones were determined by RIA or LC-MS/MS. Three-dimensional structural modeling was performed by Modeller software. All patients presented prepubertal female external genitalia, primary amenorrhea, hypergonadotrophic hypogonadism, hypokalemic hypertension, decreased cortisol, and increased ACTH and corticosterone levels. Five patients presented previously described mutations: p.W406R/p.W406R, IVS2-2A>C/p.P428L, and p.P428L/p.P428L. Two patients presented the compound heterozygous p.G478S/p.I223Nfs10 mutations, whose CYP17A1 activity and the three dimensional structural modeling are originally studied in this paper. CYP17A1 activity of p.G478S was 13 and 58% against progesterone and 17-hydroxypregnenolone, respectively. The p.I223Nfs10 caused a truncated inactive protein. Three-dimensional p.G478S structural modeling showed different internal hydrophobic interaction with W313 and created an additional chain side contact with L476 residue. Due to the rarity of 17OHD, the long term follow up (15.3±3.1 years) of our patients will help endocrinologists on the management of patients with 17OHD. The mutation p.G478S/pI223Nfs*10 led to severe 17OHD and impaired CYP17A1 structure and function. The integration of in silico and in vitro analysis showed how the amino acid changes affected the CYP17A1 activity and contributed to clarify the molecular interactions of CYP17A1.
17-羟化酶缺乏症(17OHD)是一种罕见的先天性肾上腺皮质增生症。本研究的目的是研究 17OHD 患者的临床、生化特征及随访情况,并评估突变的功能和结构。对巴西的 7 例(3 例 46,XX,4 例 46,XY;17±1.9 岁)17-羟化酶/17,20-裂解酶缺陷患者进行评估。对 基因进行测序。通过转染 COS7 细胞进行功能分析,该细胞暴露于孕酮或 17α-羟孕烯醇酮底物中。采用放射免疫或 LC-MS/MS 测定激素水平。三维结构建模采用 Modeller 软件进行。所有患者均表现为青春期前女性外生殖器、原发性闭经、促性腺激素低下性性腺功能减退、低钾性高血压、皮质醇降低、ACTH 和皮质酮水平升高。5 例患者携带先前描述的突变:p.W406R/p.W406R、IVS2-2A>C/p.P428L 和 p.P428L/p.P428L。2 例患者携带复合杂合子 p.G478S/p.I223Nfs10 突变,CYP17A1 活性和三维结构建模在本文中首次进行了研究。p.G478S 对孕酮和 17-羟孕烯醇酮的 CYP17A1 活性分别为 13%和 58%。p.I223Nfs10 导致截短的无活性蛋白。p.G478S 的三维结构建模显示与 W313 有不同的内部疏水性相互作用,并与 L476 残基形成额外的链侧接触。由于 17OHD 较为罕见,我们对患者进行了 15.3±3.1 年的长期随访,这将有助于内分泌医生对 17OHD 患者进行管理。p.G478S/p.I223Nfs*10 突变导致严重的 17OHD,并损害 CYP17A1 的结构和功能。体内外分析的整合表明,氨基酸变化如何影响 CYP17A1 的活性,并有助于阐明 CYP17A1 的分子相互作用。